The FDA has approved Auvelity for AD agitation. The combination of dextromethorphan and bupropion is the first oral non-antipsychotic approved for this indication.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/fda-oks-first-non-antipsychotic-alzheimers-agitation-2026a1000dze?src=rss
Author :
Publish date : 2026-05-01 09:46:00
Copyright for syndicated content belongs to the linked Source.
